Snapshot from Jul 20, 2026 at 07:00 UTC. For live data and tracking: View Live
Events / Regulatory / ADMA Biologics securities class action
Regulatory class action lawsuit

ADMA Biologics securities class action

Analysis based on 6 articles · First reported Jul 06, 2026 · Last updated Jul 20, 2026

Sentiment
-30
Attention
2
Articles
6
Market Impact
General
Live prominence charts, article sentiment distribution, and event development timeline available on the Ergen Dashboard
Market Impact

The lawsuit may negatively impact ADMA's stock price and investor confidence. The allegations of accounting irregularities could lead to regulatory scrutiny and potential financial penalties.

Biotechnology Pharmaceuticals
Event Summary

A securities class action lawsuit has been filed against ADMA Biologics, Inc. (NASDAQ: ADMA) by the The Schall Law Firm on behalf of investors who purchased ADMA securities between August 9, 2024 and March 25, 2026. The complaint alleges that ADMA made false and misleading statements, engaged in undisclosed related party transactions, used channel stuffing to inflate revenue, and failed to maintain adequate internal controls. When the truth emerged, investors suffered losses. The lawsuit seeks to recover damages under federal securities laws.

Key Actions
90 ADMA Biologics issued misleading information
80 The Schall Law Firm reminded investors of lawsuit ADMA Biologics
Entities Involved
stock
ADMA Biologics
ADMA Biologics is the defendant in the class action lawsuit, accused of securities fraud. The company faces potential financial liability and reputational damage.
Importance 100.0 Sentiment -40.0
priv
The Schall Law Firm
The Schall Law Firm is the plaintiff's law firm representing investors in the class action. The firm benefits from the case through legal fees.
Importance 60.0 Sentiment 0.0
govactor
United States — United States Securities and Exchange Commission
The SEC is the regulatory body that enforces securities laws. The lawsuit references SEC rules, but the SEC is not a party to the action.
Importance 40.0 Sentiment 0.0
per
Brian Schall
Brian Schall is the attorney at The Schall Law Firm handling the case. His role is to represent the investor class.
Importance 30.0 Sentiment 0.0
Relationships
The Schall Law Firm securities litigator ↔ United States — United States Securities and Exchange Commission The Schall Law Firm is a private law firm that specializes in filing securities class action lawsuits against public com
The Schall Law Firm related ↔ Brian Schall
United States — United States Securities and Exchange Commission related ↔ Brian Schall
ERGEN INTELLIGENCE
Track this event live

Set up alerts, explore entity relationships, search across thousands of events, and build custom intelligence feeds.

Open Dashboard

About Ergen

Ergen is a news intelligence platform that converts raw news articles into structured data. It tracks events, entities, and the relationships between them, with sentiment and attention metrics derived from thousands of articles. Pages on this site are daily static snapshots from the platform's live database. For real-time tracking, search, and alerts, the full dashboard is at app.ergen.ai.